XENE
Xenon Pharmaceuticals Inc ยท Health Care ยท NASDAQ
$54.79
โฒ $1.88 (+3.55%)
Market cap
$5.1B
52-week range
$30.00 โ $63.95
Volume
1.9M
Previous close
$52.91
Xenon Pharmaceuticals Inc (XENE) is held by 5 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: Driehaus Capital Management LLC.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Driehaus Capital Management LLC Driehaus Capital Management LLC |
1.9% | 4.5M | $261M | โผ 1.0% (โ47K) | $35.79 | 2026-03-31 |
| Polar Capital Holdings Plc Polar Capital Holdings Plc |
0.9% | 4.4M | $256M | โฒ 79% (+1.9M) | $35.79 | 2026-03-31 |
| ORBIMED ADVISORS LLC ORBIMED ADVISORS LLC |
1.2% | 1.1M | $62M | โฒ 137% (+613K) | $35.79 | 2026-03-31 |
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
0.1% | 370K | $22M | โ | $35.79 | 2026-03-31 |
| Duquesne Family Office Stanley Druckenmiller |
0.4% | 239K | $14K | NEW (+239K) | $0.06 | 2026-03-31 |
FAQ โพ
Which hedge funds hold XENE?
Tracked holders include: Driehaus Capital Management LLC, Polar Capital Holdings Plc, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP.
How much smart money owns XENE?
5 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading XENE?
No tracked Congressional trades in XENE on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.